SIGHT SCIENCES INC's ticker is and the CUSIP is 82657M105. A total of 70 filers reported holding SIGHT SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $361,224 | -95.6% | 41,330 | -93.8% | 0.01% | -95.2% |
Q4 2022 | $8,123,594 | +92.3% | 665,323 | 0.0% | 0.17% | +71.1% |
Q3 2022 | $4,225,000 | -52.9% | 665,323 | -33.3% | 0.10% | -58.2% |
Q2 2022 | $8,964,000 | -22.2% | 997,099 | 0.0% | 0.23% | -2.9% |
Q1 2022 | $11,526,000 | -44.6% | 997,099 | -15.8% | 0.24% | -21.4% |
Q4 2021 | $20,801,000 | -28.6% | 1,183,871 | -7.8% | 0.30% | -30.9% |
Q3 2021 | $29,144,000 | – | 1,283,871 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KCK LTD. | 4,776,232 | $42,938,000 | 60.33% |
Sio Capital Management, LLC | 724,944 | $6,517,000 | 2.45% |
D1 Capital Partners L.P. | 5,852,036 | $52,610,000 | 1.25% |
PFM Health Sciences, LP | 776,281 | $6,979,000 | 0.27% |
RTW INVESTMENTS, LP | 997,099 | $8,964,000 | 0.23% |
ArrowMark Colorado Holdings LLC | 1,587,305 | $14,270,000 | 0.16% |
Jackson Square Partners, LLC | 595,051 | $5,349,000 | 0.12% |
Atom Investors LP | 11,181 | $101,000 | 0.04% |
Bellevue Group AG | 294,606 | $2,649,000 | 0.04% |
Orbimed Advisors | 200,000 | $1,798,000 | 0.03% |